Based on these findings, we propose that MKRN2 and PPP2CA have opposite regulatory effects on β-Catenin protein expression, leading to functional equilibration of the Wnt signaling that mediates ccRCC tumor progression (Fig. 9). The gene discussed is PPP2CA; the disease is nonpapillary renal cell carcinoma.